Medicine review at the federal level sits with the US Food and Drug Administration, or FDA.
Ask what the offer actually includes
An appealing treatment name is not much to go on. Ask for the medicine’s name, who will assess you and what happens if the plan changes.
Peptide names a chain of the small pieces that make up proteins. That word alone did not mean FDA approval when sources were checked on September 26, 2026.
Rather than judge peptides as a group, ask which product is in front of you and why the clinician thinks it fits your concern.
Names to get
- The clinician who will make the decision.
- The ingredient and product name. Beside those names, write how it is supplied: perhaps tablets or an injection.
- The pharmacy that will fill a prescription.
Answers to get
- What makes this an option for my concern?
- What else could we consider, including no treatment?
- How does the bill change once the opening offer ends?
- Who takes over if I need care in person?
Follow the loose end
A visit in a room and an online assessment are care settings to discuss. Ask an existing clinician which setting could answer the concern you have.
No need to solve every question at once. A missing medicine name points to a different problem from an unclear fee.
Read the Georgia visit questionSeparate the parts of the bill